斑块旋切联合球囊扩张与单纯球囊扩张治疗股腘动脉原发病变的系统评价与荟萃分析
该系统评价与荟萃分析纳入4项随机对照试验,比较斑块旋切联合球囊扩张(BA)与单纯BA治疗股腘动脉原发狭窄闭塞性病变的疗效与安全性。结果显示联合组技术成功率更高、补救性支架植入与限流性夹层更少,但1年靶病变血运重建、一期通畅率、死亡率、主要不良事件及踝肱指数无显著差异。
要点
- 斑块旋切联合BA可提高技术成功率并减少补救性支架植入与限流性夹层。
- 联合治疗未显著改善1年一期通畅率、靶病变血运重建、死亡率或踝肱指数。
- 现有证据来自4项随机对照试验,结论仍需更多研究确认。
核心结论
- 与单纯BA相比,斑块旋切联合BA可能不改善股腘动脉病变的一期通畅率、靶病变血运重建、死亡率或踝肱指数,但可能减少补救性支架植入和限流性夹层并提高技术成功率。
研究设计与样本
- 系统评价与荟萃分析,检索Cochrane Library、Medline和Embase自建库至2020年7月,纳入4项随机对照试验。
- 采用Cochrane偏倚风险工具评估方法学质量,采用GRADE框架评估各结局证据级别。
- I2 < 50%时采用固定效应模型合并数据,否则采用随机效应模型,并进行亚组与敏感性分析。
主要发现
- 斑块旋切联合BA与技术成功率改善相关(RR 0.22,95%CI 0.13-0.38,p < .001;I2 = 0;高质量)。
- 联合组补救性支架植入减少(RR 0.15,95%CI 0.07-0.32,p < .001;I2 = 16%;高质量)。
- 联合组限流性夹层减少(RR 0.24,95%CI 0.13-0.47,p < .001;I2 = 0;高质量)。
- 1年随访时靶病变血运重建、一期通畅率、死亡率、主要不良事件及踝肱指数均无统计学显著差异。
临床怎么用
- 在股腘动脉原发狭窄闭塞性病变中,斑块旋切联合BA或可提高技术成功率并减少补救性支架与限流性夹层,但不应据此预期1年通畅率获益。
局限性
- 仅纳入4项随机对照试验,证据数量有限,作者指出需更多研究进一步确认结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The efficacy and cost effectiveness of atherectomy for femoropopliteal (FP) arterial diseases have not been determined yet. A systematic review and meta-analysis were performed to compare the efficacy and safety between atherectomy combined with balloon angioplasty (BA) and BA alone for patients with de novo FP steno-occlusive lesions. METHODS: The Cochrane Library, Medline, and Embase were used to search for studies evaluating outcomes of atherectomy combined with BA compared with BA alone in FP arterial diseases from inception to July 2020. The methodological quality of the included studies was evaluated with the Cochrane Risk of Bias Tool. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was used to assess the level of evidence for each outcome. The fixed effects model was chosen to combine the data when I2 < 50%; otherwise, the random effects model was used. Subgroup and sensitivity analyses were performed to further analyse the results. RESULTS: Four RCTs were included. The meta-analysis showed that atherectomy combined with BA was associated with improved technical success rate (risk ratio [RR] 0.22, 95% confidence interval [CI] 0.13-0.38, p < .001; I2 = 0; high quality), reduced bailout stenting (RR 0.15, 95% CI 0.07-0.32, p < .001; I2 = 16%; high quality), and flow limiting dissection (RR 0.24, 95% CI 0.13-0.47, p < .001; I2 = 0; high quality). No statistically significant difference was found in target lesion revascularisation (TLR), primary patency, mortality, major adverse event (MAE), or ankle brachial index (ABI) after one year follow up. CONCLUSION: Compared with BA alone, atherectomy combined with BA may not improve primary patency, TLR, mortality rate, or ABI, but may reduce the need for bailout stenting and the incidence of flow limiting dissection and increase the technical success rate in FP arterial diseases. More studies are warranted to further confirm the conclusion.
引用
- Wu Z, Huang Q, Pu H, et al. Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg. 2021. PMID: 34112574. doi:10.1016/j.ejvs.2021.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。